Prices are updated after-hours


Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date

publishing date : 2021 - 10 - 12    tags : Covid    save search

Amusement Parks Global Market Opportunities and Strategies to 2030: COVID-19 Impact and Recovery Analysis
Published: 2021-10-12 (Crawled : 21:00) - prnewswire.com
CMCSA | $40.36 -0.52% -0.52% 15M twitter stocktwits trandingview |
Consumer Services
| | O: 1.74% H: 0.11% C: -1.03%

covid covid-19
Global Computed Tomography (CT) Scanners Devices and Equipment Market Report 2021: COVID-19 Impact and Recovery to 2030
Published: 2021-10-12 (Crawled : 17:00) - prnewswire.com
PHG | News | $21.01 1.94% 0.0% 2M twitter stocktwits trandingview |
Health Technology
| | O: -1.26% H: 0.42% C: 0.12%

covid device
APDN Implements safeCircle™ COVID Testing Program at Sarah Lawrence
Published: 2021-10-12 (Crawled : 17:00) - adnas.com
APDN | $0.2888 -12.49% -14.27% 810K twitter stocktwits trandingview |
Commercial Services
| | O: 0.84% H: 21.5% C: 19.42%

covid covid test test program
Late in the Game, CureVac Lays Down COVID Vaccine for a Better Hand
Published: 2021-10-12 (Crawled : 15:00) - biospace.com/
SNY | News | $47.69 1.15% 1.13% 1.7M twitter stocktwits trandingview |
Health Technology
| | O: -0.72% H: 0.1% C: -0.06%

covid vaccine
Pfizer-BioNTech Lead Globally with COVID-19 Vaccine
Published: 2021-10-12 (Crawled : 15:00) - biospace.com/
JNJ | News | $149.56 0.3% 0.0% 9.1M twitter stocktwits trandingview |
Health Technology
| | O: -0.16% H: 0.11% C: -1.44%

covid vaccine covid-19
Moderna Announces COVAX Exercises Option to Purchase 176.5 Million Additional Doses of Moderna’s COVID-19 Vaccine for Low Income Countries in First Half of 2022
Published: 2021-10-12 (Crawled : 14:15) - biospace.com/
MRNA | News S | $107.87 3.26% 3.16% 2.4M twitter stocktwits trandingview |
Health Technology
| | O: 2.6% H: 0.93% C: -0.61%

covid vaccine
INOVIO Announces Online Preprint Publication of Homologous Boosting Data for its COVID-19 DNA Vaccine Candidate, INO-4800
Published: 2021-10-12 (Crawled : 13:00) - inovio.com
INO | $10.34 3.19% 3.09% 240K twitter stocktwits trandingview |
Health Technology
| | O: 2.06% H: 0.58% C: -0.29%

covid vaccine ino-4800
Aethlon Medical Announces Peer-Reviewed Publication of Two Case Studies of Critically Ill COVID-19 Patients Treated with the Hemopurifier®
Published: 2021-10-12 (Crawled : 12:00) - prnewswire.com
AEMD A | $1.5 1.35% 1.33% 17K twitter stocktwits trandingview |
Health Technology
| | O: -0.88% H: 5.64% C: 4.15%

covid
LUCIRA™ HEALTH COVID-19 Test Approved for Sale in Singapore
Published: 2021-10-12 (Crawled : 12:00) - globenewswire.com
LHDX | $0.4523 -10.46% 0 twitter stocktwits trandingview |
| | O: -0.34% H: 3.94% C: -0.86%

covid test approval sales covid-19 health
InflaRx Completes Enrollment of Vilobelimab Phase III Study in Severe COVID-19
Published: 2021-10-12 (Crawled : 12:00) - globenewswire.com
IFRX | $1.37 0.0% 97K twitter stocktwits trandingview |
Health Technology
| | O: 4.35% H: 0.0% C: -9.09%

covid enroll covid-19
Enlivex CSO Prof. Dror Mevorach Publishes Foundational Paper on the Pfizer–BioNTech COVID-19 Vaccine in The New England Journal of Medicine
Published: 2021-10-12 (Crawled : 12:00) - globenewswire.com
ENLV | News | $1.32 3.94% 3.79% 48K twitter stocktwits trandingview |
Health Technology
| | O: 1.46% H: 3.77% C: 2.88%

covid vaccine
How COVID-19 Impacted Customer Service & What's Next [Data + Expert Tips]
Published: 2021-10-12 (Crawled : 12:00) - hubspot.com
HUBS M | $651.78 2.96% 0.0% 680K twitter stocktwits trandingview |
Technology Services
| | O: 1.44% H: 17.66% C: 9.49%

covid covid-19
CureVac verlagert Fokus der COVID-19-Impfstoffentwicklung auf mRNA-Technologie der zweiten Generation
Published: 2021-10-12 (Crawled : 12:00) - curevac.com
GLAXF | News | $20.305 -14.18% 630 twitter stocktwits trandingview |
Health Technology
| | O: 3.38% H: 0.0% C: -5.75%
GSK | News | $41.24 1.6% 0.0% 2.3M twitter stocktwits trandingview |
Health Technology
| | O: 2.51% H: 0.15% C: -1.43%
CVAC | $2.585 2.17% 2.13% 610K twitter stocktwits trandingview |
Health Technology
| | O: -13.04% H: 13.08% C: 9.7%

covid covid-19
CureVac to Shift Focus of COVID-19 Vaccine Development to Second-Generation mRNA Technology
Published: 2021-10-12 (Crawled : 12:00) - biospace.com/
CVAC | $2.585 2.17% 2.13% 610K twitter stocktwits trandingview |
Health Technology
| | O: -13.04% H: 13.08% C: 9.7%

covid vaccine technology covid-19
Gainers vs Losers
78% 22%

Top 10 Gainers
MTTR | News 4 | $4.6 164.37% 62.17% 28M twitter stocktwits trandingview |

AGBA | $2.94 135.2% 57.48% 66M twitter stocktwits trandingview |
Finance

EDBL | News | $6.46 71.81% 41.8% 2M twitter stocktwits trandingview |

MTC | $2.25 44.23% 30.67% 6M twitter stocktwits trandingview |
Technology Services

OPRT | News | $3.175 41.11% 29.13% 12M twitter stocktwits trandingview |
Finance

SHIM | $3.05 35.56% 26.23% 1.1M twitter stocktwits trandingview |

HKIT | $1.345 31.86% 24.16% 390K twitter stocktwits trandingview |
Technology Services

ABVC | $1.36 30.77% 23.53% 7.4M twitter stocktwits trandingview |
Wholesale Trade

OST | $0.512 28.0% 21.88% 290K twitter stocktwits trandingview |

POET | $1.59 27.2% 21.38% 4.2M twitter stocktwits trandingview |
Manufacturing


Your saved searches
Save your searches and get alerts when important news are released.